Bioceres Crop Solutions (NASDAQ:BIOX) Hits New 1-Year Low at $10.00

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) shares reached a new 52-week low on Friday . The stock traded as low as $10.00 and last traded at $10.09, with a volume of 43521 shares. The stock had previously closed at $10.81.

Analyst Ratings Changes

Several research firms have recently commented on BIOX. Canaccord Genuity Group reissued a “buy” rating and set a $17.00 target price on shares of Bioceres Crop Solutions in a research report on Friday, July 19th. Roth Mkm began coverage on Bioceres Crop Solutions in a report on Tuesday, July 2nd. They issued a “buy” rating and a $15.00 target price on the stock. Roth Capital upgraded Bioceres Crop Solutions to a “strong-buy” rating in a report on Tuesday, July 2nd. Finally, Canaccord Genuity Group upgraded Bioceres Crop Solutions to a “strong-buy” rating in a research note on Friday, July 19th. Three research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $19.00.

Bioceres Crop Solutions Trading Down 6.4 %

The company has a debt-to-equity ratio of 0.29, a current ratio of 1.22 and a quick ratio of 0.83. The company has a market capitalization of $635.54 million, a P/E ratio of 984.00 and a beta of 0.50. The firm has a fifty day moving average price of $10.99 and a 200-day moving average price of $12.12.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its quarterly earnings data on Wednesday, May 29th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.02). The business had revenue of $83.98 million during the quarter, compared to the consensus estimate of $88.80 million. Bioceres Crop Solutions had a net margin of 0.21% and a return on equity of 0.28%. On average, equities research analysts anticipate that Bioceres Crop Solutions Corp. will post 0.35 earnings per share for the current year.

Institutional Investors Weigh In On Bioceres Crop Solutions

Large investors have recently modified their holdings of the stock. Activest Wealth Management bought a new position in Bioceres Crop Solutions during the first quarter worth about $30,000. Cape Investment Advisory Inc. purchased a new position in Bioceres Crop Solutions in the 4th quarter valued at approximately $33,000. Oppenheimer & Co. Inc. bought a new stake in Bioceres Crop Solutions during the 1st quarter valued at $139,000. Lazard Asset Management LLC purchased a new stake in shares of Bioceres Crop Solutions during the first quarter worth $212,000. Finally, One Degree Advisors Inc bought a new position in shares of Bioceres Crop Solutions in the fourth quarter worth $291,000. Hedge funds and other institutional investors own 17.68% of the company’s stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.